RecruitingNCT04969926
Endocrine
Parathyroid carcinoma
8
studies recruiting now
as of 7 Sept 2026
38
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
17 Mar 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2 / Phase 3NCT07444723
Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
RecruitingNCT03039439
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
RecruitingPhase 2NCT06638931
Agnostic Therapy in Rare Solid Tumors
RecruitingNot applicableNCT07475780
Radiofrequency Ablation For Recurrent Parathyroid Carcinoma
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 8 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Parathyroid carcinoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Parathyroid carcinoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (CDC73).
Treatments being studied
1 approved treatment, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Cinacalcet Hydrochloride (Cinacalcet accordpharma)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).